Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

shLuc pRRL Citations (3)

Originally described in: Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression.
Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, Liu A, Miu K, Watnick RS, Reinhardt F, McAllister SS, Jacks T, Weinberg RA Cell. 2008 Jul 11. 134(1):62-73.
PubMed Journal

Articles Citing shLuc pRRL

Articles
Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells. Weitzenfeld P, Meshel T, Ben-Baruch A. Oncotarget. 2016 Dec 6;7(49):81123-81143. doi: 10.18632/oncotarget.13213. PubMed
Acute Myeloid and Lymphoblastic Leukemia Cell Interactions with Endothelial Selectins: Critical Role of PSGL-1, CD44 and CD43. Spertini C, Baisse B, Bellone M, Gikic M, Smirnova T, Spertini O. Cancers (Basel). 2019 Aug 27;11(9). pii: cancers11091253. doi: 10.3390/cancers11091253. PubMed
Targeting Opsin4/Melanopsin with a Novel Small Molecule Suppresses PKC/RAF/MEK/ERK Signaling and Inhibits Lung Adenocarcinoma Progression. Wang Q, Zhang T, Chang X, Wang K, Lee MH, Ma WY, Liu K, Dong Z. Mol Cancer Res. 2020 Jul;18(7):1028-1038. doi: 10.1158/1541-7786.MCR-19-1120. Epub 2020 Apr 8. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.